glp 1 incretin mimetics Novel therapeutics for type 2 diabetes: hormone (glucagon-like peptide-1 receptor agonists) and dipeptidyl peptidase-4 inhibitors Non-insulin injectable antidiabetic drugs -

GLP-1 drugs have been around for more than a decade to help people manage type 2 diabetes, but the ones developed in recent yearsOzempic, Wegovy, Mounjaro, and Zepboundhave exploded in popularity after becoming the worst-kept celebrity weight-loss secret

The Impact of GLP-1 Weight Loss Medications on Hair Health: What Salon Clients Need to Know As GLP-1 receptor agonists such as Ozempic, Wegovy, and Mounjaro gain popularity for medical weight loss, more clients are arriving at Creations Hair Salon with concerns about hair thinning and unexpected shedding

Using microsimulation modeling, she evaluates cost-effectiveness and long-term outcomes to support data-driven, equitable obesity care

Nausea and vomiting are among the most common side effects from GLP-1 injections, such as semaglutide (Wegovy) and tirzepatide (Mounjaro), for weight management or diabetes control